| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5880782 | Journal of Pain and Symptom Management | 2015 | 8 Pages |
Abstract
The ESAS-CS and ESAS-r-CS NRS versions are valid and reliable for measuring symptoms in this population of outpatients with advanced cancer. Although the ESAS-r-CS was preferred, patients favored the 24-hour time window of the ESAS-CS, which also may best characterize fluctuating symptoms.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Breffni MBChB, Martin MD, Ashley BSc, Nadia BSc, Subrata MD, Ernie MD, John MD, Gary MD, Julia MD, MSc, Chris PhD, Lisa W. MSc, Camilla MD, PhD,